TAGS: Skin Care
Givaudan Active Beauty launches Neoporyl™, an active ingredient that reduces the size of enlarged pores by targeting the biological root causes of parakeratosis, an alteration of the epidermal structure, and dermis fragility. The new active is crafted by biocatalysis to offer proven efficacy against enlarged pores in just one week.
Pores & Related Concerns
Beauty consumers of every age, gender, and skin type commonly complain about enlarged pores. Perceived as a sign of premature aging, pore size has become as much of a concern as fine lines and wrinkles. The importance of this issue for skincare consumers is such that a new term has been coined to describe a fixation with pore size, porexia.
Strongly driven by genetics and environmental factors, enlarged pores are caused by two main factors, parakeratosis, and dermis fragility. Neoporyl™ effectively counteracts both of these key biological causes.
Mathias Fleury, head of the actives category for Active Beauty, said: “
Our experts in Skin Physiology and White biotechnology have designed Neoporyl™, an innovative complex based on a biomimetic source of energy and key amino acids, to address the biological phenomena of parakeratosis and skin fragility. Our active ingredient is able to limit hyper differentiation in the epidermis, reduce nucleated cell density in the stratum corneum, restore collagen production in the fragile dermis, and boost mature collagen and decorin production.”
Explore Product Range from Givaudan
Source: Givaudan
